Cyclosporin: revisions in monitoring guidelines and review of current analytical methods, Annals of Clinical Biochemistry, vol.39, issue.5, pp.424-435, 2002. ,
DOI : 10.1258/000456302320314430
Three commercial polyclonal immunoassays for cyclosporine in whole blood compared: 1. Results with patient's specimens, Clin Chem, vol.36, pp.115-118, 1990. ,
Measurement of cyclosporine by liquid chromatography and three immunoassays from liver, cardiac and renal transplant recipients, Clin Chem, vol.38, pp.2300-2306, 1992. ,
Robotic automation of cyclosporine analysis in whole blood, Clin Chem, vol.38, pp.1440-1443, 1992. ,
Rapid liquid chromatographytandem mass spectrometry method for simultaneous determination of sirolimus, tacrolimus and cyclosporine A in whole blood, Clin Chem, vol.48, pp.955-958, 2002. ,
A monoclonal antibody fluorescent polarization immunoassay for cyclosporine, Transplant Proc, vol.22, pp.1186-1188, 1990. ,
Evaluation of EMIT cyclosporine assay for use with whole blood, Clin Chem, vol.39, pp.2235-2241, 1993. ,
Cyclosporine whole blood immunoassays (AxSYM, CEDIA and EMIT): a critical overview of performance characteristics and comparison with HPLC, Clin Chem, vol.44, pp.2158-2164, 1998. ,
Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: How specific is specific?, Clin Chem, vol.45, pp.371-381, 1999. ,
Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood, Clin Chem, vol.36, pp.1969-1973, 1990. ,
Evaluation of the new AxSYM cyclosporine assay: Comparison with TDx monoclonal whole blood and EMIT cyclosporine assays, Clin Chem, vol.45, pp.432-435, 1999. ,
Evaluation of a no-Pretreatment cyclosporin A assay on the Dade Behring Dimension RxL clinical chemistry analyzer, Clin Chem, vol.48, pp.1059-1065, 2002. ,
Basic Method Validation, pp.168-174 ,
A new biometrical procedure for testing the equality of measurements from two different analytical methods, J Clin Chem Clin Biochem, vol.21, pp.709-720, 1983. ,
CsA immunoassays in comparison to LC-MS/MS, is there a difference between trough (C0) and C2 levels?, Ther Drug Monit, vol.23, p.471, 2001. ,
Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay, Therapeutic Drug Monitoring, vol.31, issue.2, pp.198-204, 2009. ,
DOI : 10.1097/FTD.0b013e31819c6a37
Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer, Clinical Biochemistry, vol.42, issue.15, pp.1543-1548, 2009. ,
DOI : 10.1016/j.clinbiochem.2009.06.018
Inter-laboratory differences in sirolimus results from six sirolimus testing centers using HPLC tandem mass spectrometry (LC/MS/MS), Clinica Chimica Acta, vol.355, issue.1-2, pp.211-213, 2005. ,
DOI : 10.1016/j.cccn.2005.01.005
Identification and analysis of nine metabolites of cyclosporine in whole blood by liquid chromatography. 2: comparison of patients results, Clin Chem, vol.33, pp.1851-1855, 1987. ,
Therapeutic drug monitoring of cyclosporine and tacrolimus, Clinical Biochemistry, vol.31, issue.5, pp.309-316, 1998. ,
DOI : 10.1016/S0009-9120(98)00049-6
Therapeutic drug monitoring of cyclosporine, Transplantation Proceedings, vol.36, issue.2, pp.396-403, 2004. ,
DOI : 10.1016/j.transproceed.2004.01.013
Lack of specificity of cyclosporine immunoassays?results of a College of American Pathologists Study, Arch Pathol Lab Med, vol.127, pp.19-22, 2003. ,
Cyclosporin Measurement ??? who cares about inaccuracy?, Accreditation and Quality Assurance, vol.6, issue.9, pp.405-408, 2001. ,
DOI : 10.1007/PL00010465